Review



anti hnf4α polyclonal rabbit antibody  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Bioss anti hnf4α polyclonal rabbit antibody
    Anti Hnf4α Polyclonal Rabbit Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti hnf4α polyclonal rabbit antibody/product/Bioss
    Average 94 stars, based on 8 article reviews
    anti hnf4α polyclonal rabbit antibody - by Bioz Stars, 2026-02
    94/100 stars

    Images



    Similar Products

    94
    Bioss anti hnf4α polyclonal rabbit antibody
    Anti Hnf4α Polyclonal Rabbit Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti hnf4α polyclonal rabbit antibody/product/Bioss
    Average 94 stars, based on 1 article reviews
    anti hnf4α polyclonal rabbit antibody - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc rabbit polyclonal anti hnf4α
    Rabbit Polyclonal Anti Hnf4α, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti hnf4α/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    rabbit polyclonal anti hnf4α - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    90
    Funakoshi ltd polyclonal rabbit anti-hnf4α bs3828r
    Polyclonal Rabbit Anti Hnf4α Bs3828r, supplied by Funakoshi ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal rabbit anti-hnf4α bs3828r/product/Funakoshi ltd
    Average 90 stars, based on 1 article reviews
    polyclonal rabbit anti-hnf4α bs3828r - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    94
    Bioss rabbit anti hnf4α antibody
    Rabbit Anti Hnf4α Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti hnf4α antibody/product/Bioss
    Average 94 stars, based on 1 article reviews
    rabbit anti hnf4α antibody - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology antibody (rabbit polyclonal) anti-hnf4α

    Antibody (Rabbit Polyclonal) Anti Hnf4α, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibody (rabbit polyclonal) anti-hnf4α/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    antibody (rabbit polyclonal) anti-hnf4α - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Bioss rabbit-polyclonal-anti hnf4α
    Gene expression analysis. (A) <t>Hnf4α</t> network in Oct3 -/- (n=3) mice. Network shapes: Double circle, complex/group; diamond, enzyme; square, growth factor; box, ion channel; triangle, kinase; circle, other; green, upregulated genes; red, downregulated genes; line, direct interaction; dashed line, indirect interaction; arrow, causation. (B) Hnf4α dependent genes in Oct3 -/- (n=3) mice. The majority of Hnf4α dependent genes in Oct3 -/- mice is upregulated. (C) Activation status (z-score) of the three top upstream regulators in Oct3 -/- mice (n=3); while myc and kras are significantly upregulated, tp53 is significantly downregulated in Oct3 -/- compared to WT mice. Results were normalized to WT results. **** P<0.0001 vs. WT mice. Hnf4α, hepatocyte nuclear factor 4α; Oct3 -/- , Oct3-knockout (FVB.Slc22a3tm10pb); N.s., not significant.
    Rabbit Polyclonal Anti Hnf4α, supplied by Bioss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit-polyclonal-anti hnf4α/product/Bioss
    Average 90 stars, based on 1 article reviews
    rabbit-polyclonal-anti hnf4α - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology rabbit polyclonal anti-hnf4α sc-8987
    Gene expression analysis. (A) <t>Hnf4α</t> network in Oct3 -/- (n=3) mice. Network shapes: Double circle, complex/group; diamond, enzyme; square, growth factor; box, ion channel; triangle, kinase; circle, other; green, upregulated genes; red, downregulated genes; line, direct interaction; dashed line, indirect interaction; arrow, causation. (B) Hnf4α dependent genes in Oct3 -/- (n=3) mice. The majority of Hnf4α dependent genes in Oct3 -/- mice is upregulated. (C) Activation status (z-score) of the three top upstream regulators in Oct3 -/- mice (n=3); while myc and kras are significantly upregulated, tp53 is significantly downregulated in Oct3 -/- compared to WT mice. Results were normalized to WT results. **** P<0.0001 vs. WT mice. Hnf4α, hepatocyte nuclear factor 4α; Oct3 -/- , Oct3-knockout (FVB.Slc22a3tm10pb); N.s., not significant.
    Rabbit Polyclonal Anti Hnf4α Sc 8987, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti-hnf4α sc-8987/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal anti-hnf4α sc-8987 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    Journal: eLife

    Article Title: TAZ inhibits glucocorticoid receptor and coordinates hepatic glucose homeostasis in normal physiological states

    doi: 10.7554/eLife.57462

    Figure Lengend Snippet:

    Article Snippet: Antibody , (Rabbit polyclonal) anti-HNF4α , Santa Cruz Biotechnology , Cat. #: sc-8987 RRID: AB_2116913 , PMID: 29937200 IB (1:000).

    Techniques: Blocking Assay, Plasmid Preparation, Expressing, Enzyme-linked Immunosorbent Assay, Reporter Assay, Mutagenesis, cDNA Synthesis, Extraction, Glucose Oxidase Assay, Recombinant, Construct, Control, Knockdown, Generated, Sequencing, Cell Culture, In Vivo, Protease Inhibitor, SYBR Green Assay, Membrane, Transfection

    Gene expression analysis. (A) Hnf4α network in Oct3 -/- (n=3) mice. Network shapes: Double circle, complex/group; diamond, enzyme; square, growth factor; box, ion channel; triangle, kinase; circle, other; green, upregulated genes; red, downregulated genes; line, direct interaction; dashed line, indirect interaction; arrow, causation. (B) Hnf4α dependent genes in Oct3 -/- (n=3) mice. The majority of Hnf4α dependent genes in Oct3 -/- mice is upregulated. (C) Activation status (z-score) of the three top upstream regulators in Oct3 -/- mice (n=3); while myc and kras are significantly upregulated, tp53 is significantly downregulated in Oct3 -/- compared to WT mice. Results were normalized to WT results. **** P<0.0001 vs. WT mice. Hnf4α, hepatocyte nuclear factor 4α; Oct3 -/- , Oct3-knockout (FVB.Slc22a3tm10pb); N.s., not significant.

    Journal: Experimental and Therapeutic Medicine

    Article Title: Functional inhibition of Oct leads to HNF4α upregulation

    doi: 10.3892/etm.2021.9780

    Figure Lengend Snippet: Gene expression analysis. (A) Hnf4α network in Oct3 -/- (n=3) mice. Network shapes: Double circle, complex/group; diamond, enzyme; square, growth factor; box, ion channel; triangle, kinase; circle, other; green, upregulated genes; red, downregulated genes; line, direct interaction; dashed line, indirect interaction; arrow, causation. (B) Hnf4α dependent genes in Oct3 -/- (n=3) mice. The majority of Hnf4α dependent genes in Oct3 -/- mice is upregulated. (C) Activation status (z-score) of the three top upstream regulators in Oct3 -/- mice (n=3); while myc and kras are significantly upregulated, tp53 is significantly downregulated in Oct3 -/- compared to WT mice. Results were normalized to WT results. **** P<0.0001 vs. WT mice. Hnf4α, hepatocyte nuclear factor 4α; Oct3 -/- , Oct3-knockout (FVB.Slc22a3tm10pb); N.s., not significant.

    Article Snippet: Primary murine hepatocytes were incubated with rabbit-polyclonal-anti Hnf4α (Bioss Antibodies Inc.) as the primary antibody after preincubation with hydrogen peroxide for blocking of endogenous peroxidase.

    Techniques: Expressing, Activation Assay, Knock-Out

    Hnf4α downregulation in cholestasis and fibrosis. (A) Hnf4α mRNA expression in 4 weeks old untreated Oct3 -/- (n=5) and WT mice (n=5); no significant difference was detected. (B) Hnf4α mRNA expression in Oct3 -/- (n=6) and WT mice (n=6) 7 days after BDL; Hnf4α mRNA expression was significantly downregulated in Oct3 -/- mice. Sham operation served as control. Values are expressed as fold expression relative to the control. (C) Hnf4α mRNA expression in Oct3 -/- (n=7) and WT mice (n=9) after 6 weeks of CCl 4 treatment: Hnf4α mRNA expression was significantly downregulated in Oct3 -/- mice. Oral gavage of mineral oil served as the control. Values are expressed as fold expression relative to the control. (D) Results of Hnf4α mRNA expression after induction of fibrosis with TAA for 6 weeks and after reversal for one and four weeks in C57BL/6 mice (n=5). Placebo intraperitoneal injection and oral gavage of mineral oil served as the control. (E) Results of Hnf4α mRNA expression after induction of fibrosis with CCl 4 for 6 weeks and after reversal for one and four weeks in C57BL/6 mice (n=5). Placebo intraperitoneal injection and oral gavage of mineral oil served as the control. (F) Correlation of Hnf4α and Oct1 mRNA expression after induction of fibrosis with TAA and CCl 4 for 6 weeks and after reversal for one and four weeks in C57BL/6 mice (n=5). * P<0.05, ** P<0.01; *** P<0.001; **** P<0.00001 vs. Control. Hnf4α, hepatocyte nuclear factor 4α; Oct3 -/- , Oct3-knockout (FVB.Slc22a3tm10pb); WT, wild type; TAA, thioacetamide; CCl 4 , carbon tetrachloride; BDL, bile duct ligation; n.s., not significant; w, weeks; rev, reversal.

    Journal: Experimental and Therapeutic Medicine

    Article Title: Functional inhibition of Oct leads to HNF4α upregulation

    doi: 10.3892/etm.2021.9780

    Figure Lengend Snippet: Hnf4α downregulation in cholestasis and fibrosis. (A) Hnf4α mRNA expression in 4 weeks old untreated Oct3 -/- (n=5) and WT mice (n=5); no significant difference was detected. (B) Hnf4α mRNA expression in Oct3 -/- (n=6) and WT mice (n=6) 7 days after BDL; Hnf4α mRNA expression was significantly downregulated in Oct3 -/- mice. Sham operation served as control. Values are expressed as fold expression relative to the control. (C) Hnf4α mRNA expression in Oct3 -/- (n=7) and WT mice (n=9) after 6 weeks of CCl 4 treatment: Hnf4α mRNA expression was significantly downregulated in Oct3 -/- mice. Oral gavage of mineral oil served as the control. Values are expressed as fold expression relative to the control. (D) Results of Hnf4α mRNA expression after induction of fibrosis with TAA for 6 weeks and after reversal for one and four weeks in C57BL/6 mice (n=5). Placebo intraperitoneal injection and oral gavage of mineral oil served as the control. (E) Results of Hnf4α mRNA expression after induction of fibrosis with CCl 4 for 6 weeks and after reversal for one and four weeks in C57BL/6 mice (n=5). Placebo intraperitoneal injection and oral gavage of mineral oil served as the control. (F) Correlation of Hnf4α and Oct1 mRNA expression after induction of fibrosis with TAA and CCl 4 for 6 weeks and after reversal for one and four weeks in C57BL/6 mice (n=5). * P<0.05, ** P<0.01; *** P<0.001; **** P<0.00001 vs. Control. Hnf4α, hepatocyte nuclear factor 4α; Oct3 -/- , Oct3-knockout (FVB.Slc22a3tm10pb); WT, wild type; TAA, thioacetamide; CCl 4 , carbon tetrachloride; BDL, bile duct ligation; n.s., not significant; w, weeks; rev, reversal.

    Article Snippet: Primary murine hepatocytes were incubated with rabbit-polyclonal-anti Hnf4α (Bioss Antibodies Inc.) as the primary antibody after preincubation with hydrogen peroxide for blocking of endogenous peroxidase.

    Techniques: Expressing, Injection, Knock-Out, Ligation

    Oct inhibition leads to Hnf4α upregulation. (A) Hnf4α mRNA expression in stably OCT1 (pcDNAOCT1)- and OCT3 (pcDNAOCT3)-transfected HepG2 (n=4) and HuH7 (n=4) cells after 48 h of treatment with 250 µM of the non-selective OCT inhibitor quinine: OCT inhibition leads to Hnf4α mRNA upregulation. Values are expressed as fold expression relative to empty vector in transfected tumour cell lines. Control groups were HepG2 and HuH7 cells transfected with the empty vector. (B) Hnf4α mRNA expression in primary murine hepatocytes (Oct3 -/- ): n=4, WT: n=6) after 48 h of treatment with 250 µM of the non-selective OCT inhibitor quinine: OCT inhibition leads to Hnf4α mRNA upregulation. Untreated primary murine hepatocytes served as control. (C) Representative western blots including densitometry and immunofluorescence (magnification, x10) in primary murine hepatocytes of two Oct3 -/- and WT mice after 48 h treatment with escalating quinine doses (0, 50, 100 and 150 µM). * P<0.05; ** P<0.01; **** P<0.0001 vs. 0 µM quinine. n.s., not significant; Hnf4α, hepatocyte nuclear factor 4α; Oct3 -/- , Oct3-knockout (FVB.Slc22a3tm10pb), WT, wild-type.

    Journal: Experimental and Therapeutic Medicine

    Article Title: Functional inhibition of Oct leads to HNF4α upregulation

    doi: 10.3892/etm.2021.9780

    Figure Lengend Snippet: Oct inhibition leads to Hnf4α upregulation. (A) Hnf4α mRNA expression in stably OCT1 (pcDNAOCT1)- and OCT3 (pcDNAOCT3)-transfected HepG2 (n=4) and HuH7 (n=4) cells after 48 h of treatment with 250 µM of the non-selective OCT inhibitor quinine: OCT inhibition leads to Hnf4α mRNA upregulation. Values are expressed as fold expression relative to empty vector in transfected tumour cell lines. Control groups were HepG2 and HuH7 cells transfected with the empty vector. (B) Hnf4α mRNA expression in primary murine hepatocytes (Oct3 -/- ): n=4, WT: n=6) after 48 h of treatment with 250 µM of the non-selective OCT inhibitor quinine: OCT inhibition leads to Hnf4α mRNA upregulation. Untreated primary murine hepatocytes served as control. (C) Representative western blots including densitometry and immunofluorescence (magnification, x10) in primary murine hepatocytes of two Oct3 -/- and WT mice after 48 h treatment with escalating quinine doses (0, 50, 100 and 150 µM). * P<0.05; ** P<0.01; **** P<0.0001 vs. 0 µM quinine. n.s., not significant; Hnf4α, hepatocyte nuclear factor 4α; Oct3 -/- , Oct3-knockout (FVB.Slc22a3tm10pb), WT, wild-type.

    Article Snippet: Primary murine hepatocytes were incubated with rabbit-polyclonal-anti Hnf4α (Bioss Antibodies Inc.) as the primary antibody after preincubation with hydrogen peroxide for blocking of endogenous peroxidase.

    Techniques: Inhibition, Expressing, Stable Transfection, Transfection, Plasmid Preparation, Western Blot, Immunofluorescence, Knock-Out